Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Imaging Canada Liquidating Corp IMRSQ

IMRIS Inc designs, manufactures and markets Image-guided therapy systems that improves the effectiveness of therapy delivery. Its main product is the Visius surgical theater. The company provides its products to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular and cardiovascular markets. The firm is focused on bringing enhanced visualization to the point of therapy delivery and is spread across Canada, United States, Europe and the Middle East and Asia-Pacific.


GREY:IMRSQ - Post by User

Post by strelioffon Aug 09, 2010 11:39am
423 Views
Post# 17333636

Imris will get a cut of China's $124 billion US do

Imris will get a cut of China's $124 billion US doOver the past year the Central Committee of the Communist Party of Chinaand the State Council have expanded on what China’s version of healthcare reform will encompass. Most importantly, it will include thespending of approximately 850 billion Yuan ($124 billion US dollars)over the next three years. One of the cornerstones of this reform is theconstruction of an astounding number of new hospitals and health carefacilities throughout rural China. Each of these new hospitals willrequire initial equipment purchases, as well as a new source of medicalsupplies and pharmaceuticals. These health care reform activities willclearly drive increased utilization in China.

In the meantime I wish Siemens would pull their US listing for legal reasons....
Bullboard Posts